Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival
Figure 1
Kaplan-Meier survival analysis of 34 patients with PMCA from appendix cancer treated with neoadjuvant chemotherapy (median survival 37.2 months) compared to 24 patients who did not receive neoadjuvant chemotherapy prior cytoreduction and HIPEC (median survival 50.5 months). The difference in survival is not significant .
